What You Need to Know
• Jenney Bitner, 38, discovered she had Stage IV melanoma after experiencing severe symptoms while pregnant.
• An MRI revealed a large brain tumor, prompting immediate surgery to remove most of the mass.
• Bitner’s doctors recommended aggressive treatment, but immunotherapy posed risks to her unborn child.
Jenney Bitner, a 38-year-old woman, was diagnosed with Stage IV melanoma after experiencing severe symptoms while pregnant with her fourth child in 2020. During a family trip to San Diego, Bitner felt unwell and sought medical attention, leading to an MRI that revealed a large brain tumor. Following surgery to remove most of the tumor, further tests indicated that the melanoma had spread to her brain and back. Doctors advised that she would need aggressive treatment, including immunotherapy, but this posed risks to her unborn child, necessitating early delivery for safe treatment to begin.
Why It Matters
This situation highlights the complexities of treating cancer during pregnancy, particularly with aggressive forms like Stage IV melanoma. The American Cancer Society reports that patients with advanced melanoma have a five-year survival rate of approximately 35%. Bitner’s case underscores the challenges faced by healthcare providers in balancing effective cancer treatment with the safety of both mother and child, especially when the mother is diagnosed at a young age.
Read the Full Story →
